Adamant Health’s technology is based on research
Filter by category: Parkinson’s disease | Epilepsy | All
Detecting negative myoclonus during long-term home measurements using wearables
Clinical Neurophysiology, 2023:156:166–174 – A. Sinokki, L. Säisänen, J. Hyppönen, K. Silvennoinen, R. Kälviäinen, E. Mervaala, P. Karjalainen, S. Rissanen
Positive and negative myoclonus monitoring using ambulatory surface EMG and 3D accelerometry
International Parkinson and Movement Disorder Society 2023 International Congress; 38 (suppl 1), Abstract number 1792 – S. Rissanen, A. Sinokki, J. Hyppönen, L. Säisänen, K. Silvennoinen, P. Karjalainen, E. Mervaala, Z. Hadj-Allal, R. Kälviäinen
Wearable monitoring of positive and negative myoclonus in progressive myoclonic epilepsy type 1
Clinical Neurophysiology, 2021:132(10):2464–2472 – S. Rissanen, J. Hyppönen, K. Silvennoinen, L. Säisänen, P. Karjalainen, E. Mervaala, R. Kälviäinen
Newsletter
Be the first to know about our new technology, events & other updates.